POMDOCTOR Ltd (POM) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
POMDOCTOR Ltd (POM) Earnings Overview
As of July 8, 2026, POMDOCTOR Ltd (POM) reported trailing twelve-month net income of -$213M, reflecting +83.2% year-over-year growth. The company earned $-3.66 per diluted share over the past four quarters, with a net profit margin of -53.2%.
Looking at the long-term picture, POM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$126M in fiscal 2022.
POMDOCTOR Ltd is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TDOC (-$171M net income, -7.9% margin), AMWL (-$88M net income, -38.4% margin), HIMS (-$13M net income, 5.5% margin), POM has room to improve margins relative to the peer group. Compare POM vs TDOC →
POM Earnings vs Peers
Earnings metrics vs comparable public companies
POM Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$213M | -48.3% | -$116M | $-3.66 | -53.2% | -29.1% |
| 2024 | -$143M | +1.4% | -$26M | $-21.78 | -41.9% | -7.5% |
| 2023 | -$145M | -15.8% | -$22M | $-22.14 | -47.7% | -7.3% |
| 2022 | -$126M | +33.4% | -$4M | $-19.08 | -51.2% | -1.5% |
| 2021 | -$188M | - | -$80M | $-28.62 | -87.5% | -37.0% |
Download Data
Export POM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
POM — Frequently Asked Questions
Quick answers to the most common questions about buying POM stock.
What is POM earnings per share (EPS)?
POM trailing twelve-month (TTM) diluted EPS is $-3.66, reflecting +83.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is POMDOCTOR Ltd's net income?
POMDOCTOR Ltd (POM) trailing twelve-month net income is $-213M as of 2025. Earnings grew +83.2% year-over-year.
Is POM profitable?
POM is not currently profitable on a TTM basis, reporting a net loss of $-213M. Net margin is -53.2%. Investors should monitor for a return to profitability.
What is POM's earnings growth rate?
POM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are POM's profit margins?
POMDOCTOR Ltd net profit margin is -53.2%, operating margin is -29.1%, and gross margin is +13.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is POM growing earnings?
Yes, POM earnings are accelerating — EPS growth of +83.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-213M. Earnings momentum is strengthening.
What was POM's best earnings year?
POMDOCTOR Ltd's highest annual net income on record is $-126M, achieved in fiscal year 2022. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.